Blanc, 179 patient metformin prophylaxis study: 79% lower mortality [p=0.06] and 44% more cases [p=0.12] https://c19p.org/blanc
copied to clipboard
Therapeutic prevention of COVID-19 in elderly: a case–control study
et al., GeroScience, doi:10.1007/s11357-021-00397-z
Retrospective 179 patients in France exposed to COVID-19 showing, without statistical significance, a higher risk of cases, and a lower risk of mortality among cases with existing metformin treatment.
|
risk of death, 78.6% lower, RR 0.21, p = 0.06, treatment 1 of 14 (7.1%), control 25 of 75 (33.3%), NNT 3.8, COVID+.
|
|
risk of case, 43.7% higher, RR 1.44, p = 0.12, treatment 11 of 16 (68.8%), control 78 of 163 (47.9%).
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Blanc et al., 17 Jul 2021, retrospective, France, peer-reviewed, 22 authors.
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.